The study, which was published in the Journal of Sports Science & Medicine in 2021, had nine healthy people use the treadmill ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...